» Articles » PMID: 23189166

Decrease in Proportion of CD19+ CD24(hi) CD27+ B Cells and Impairment of Their Suppressive Function in Graves' Disease

Overview
Journal PLoS One
Date 2012 Nov 29
PMID 23189166
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

IL-10-producing B cells (B10 cells) have been shown to play a suppressive role in the peripheral blood of humans, with their numbers and function altered in several autoimmune diseases. However, the role of B10 cells in Graves' disease (GD) remains unknown. In this study, we demonstrated that B10 cells in human peripheral blood belonged to a CD24(hi)CD27(+) B cell subpopulation. The proportion of B10 cells along with the CD19(+)CD24(hi)CD27(+) B cell subset was significantly lower in new-onset patients compared with healthy individuals. In recovered patients, these proportions were restored to levels similar to those seen in healthy individuals. Additionally, we found that CD19(+)CD24(hi)CD27(+) B cells from healthy individuals inhibited proliferation and TNF-α production of CD4(+) T cells via an IL-10-independent pathway. They also inhibited IFN-γ production by CD4(+) T cells, through an IL-10-dependent pathway. In contrast, their suppressive function on CD4(+) T cell proliferation and cytokine production was impaired in new-onset and recovered patients compared with healthy individuals. Our study provides evidence that CD19(+)CD24(hi)CD27(+) B cells may possess the capacity to downregulate immune responses, partially by production of IL-10 in human peripheral blood. Impairment of their immunosuppressive function may contribute to GD pathogenesis and relapse.

Citing Articles

Single-cell BCR and transcriptome analysis reveals peripheral immune signatures in patients with thyroid-associated ophthalmopathy.

Li Q, An N, Liu C, Ding Y, Yang C, Ma X Aging (Albany NY). 2024; 16(9):8217-8245.

PMID: 38728262 PMC: 11132005. DOI: 10.18632/aging.205814.


Characterizing the Interplay of Lymphocytes in Graves' Disease.

Hansen M, Cheever A, Weber K, ONeill K Int J Mol Sci. 2023; 24(7).

PMID: 37047805 PMC: 10094834. DOI: 10.3390/ijms24076835.


New Chromones from (Cav.) Schltdl with Anti-Inflammatory and Immunomodulatory Activity.

Lopera Y, Jimenez-Ferrer E, Herrera-Ruiz M, Zamilpa A, Gonzalez-Cortazar M, Rosas-Salgado G Plants (Basel). 2023; 12(1).

PMID: 36616130 PMC: 9823701. DOI: 10.3390/plants12010001.


The emerging role of regulatory cell-based therapy in autoimmune disease.

Ghobadinezhad F, Ebrahimi N, Mozaffari F, Moradi N, Beiranvand S, Pournazari M Front Immunol. 2023; 13:1075813.

PMID: 36591309 PMC: 9795194. DOI: 10.3389/fimmu.2022.1075813.


Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease.

Torimoto K, Okada Y, Nakayamada S, Kubo S, Kurozumi A, Narisawa M Sci Rep. 2022; 12(1):16880.

PMID: 36207336 PMC: 9546934. DOI: 10.1038/s41598-022-19556-z.


References
1.
Cooper D . Hyperthyroidism. Lancet. 2003; 362(9382):459-68. DOI: 10.1016/S0140-6736(03)14073-1. View

2.
Bouaziz J, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A . IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010; 40(10):2686-91. DOI: 10.1002/eji.201040673. View

3.
Chen X, Jensen P . Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells. J Immunol. 2007; 179(4):2046-50. DOI: 10.4049/jimmunol.179.4.2046. View

4.
Blair P, Norena L, Flores-Borja F, Rawlings D, Isenberg D, Ehrenstein M . CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010; 32(1):129-40. DOI: 10.1016/j.immuni.2009.11.009. View

5.
Wilson M, Taylor M, OGorman M, Balic A, Barr T, Filbey K . Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol. 2010; 40(6):1682-96. PMC: 3179601. DOI: 10.1002/eji.200939721. View